Table 3.
Treatment characteristics of patients experiencing grade 3–5 toxic effects after definitive radiotherapy for para-aortic recurrence
| Grade of toxic effect | Type of toxic effect | Age, years | Location of para-aortic recurrence | GTV1 (cc) | Prior Pelvic RT | Surgical debulking | Neoadjuvant or adjuvant chemotherapy | Concurrent chemotherapy | Maximum dose (Gy) / fraction no. | Small bowel maximum / mean dose (Gy) |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 | Duodenal fistula | 59 | L4–L5 | 31 | No | No | Yes | Cisplatin | 66 / 30 | 64.3 / 21.5 |
| 4 | Small bowel fistula | 63 | T12 | 2.6 | No | Yes | No | None | 63 / 28 | 56.1 / 24.7 |
| 4 | Small bowel perforation | 54 | L3–L4 | 15 | No | Yes | Yes | Cisplatin | 63.8 / 29 | 69.0 / 26.0 |
| 4 | Duodenal fistula | 78 | L3 | 17 | Yes | No | Yes | Cisplatin | 61.6 / 28 | 61.1 / 23.5 |
| 3 | Small bowel obstruction | 53 | L1–L2 | 10 | Yes | Yes | Yes | Cisplatin | 64.12 / 28 | 65 / 16.2 |
GTV, gross tumor volume.